Restoration of self-tolerance is a feasible approach to control ongoing beta-cell specific autoreactivity: its relevance for treatment in established diabetes and islet transplantation
Data up to Jan 2025
Total Citations Per Year
Abstract
References (41)
Reshaping human antibodies for therapy
1988 • 1,555 citations
CD4pos, NK1.1pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3.
1994 • 862 citations
OKT3: A monoclonal anti-human T lymphocyte antibody with potent mitogenic properties
1980 • 718 citations
The Nonobese Diabetic Mouse as a Model of Autoimmune Diabetes: Immune Dysregulation Gets the NOD
1997 • 685 citations
Recurrent diabetes mellitus in the pancreas iso- and allograft. A light and electron microscopic and immunohistochemical analysis of four cases.
1985 • 387 citations
RELEASE OF TUMOR NECROSIS FACTOR, INTERLEUKIN-2, AND GAMMA-INTERFERON IN SERUM AFTER INJECTION OF OKT3 MONOCLONAL ANTIBODY IN KIDNEY TRANSPLANT RECIPIENTS
1989 • 361 citations
T cell suppression in transplantation tolerance through linked recognition.
1996 • 246 citations
HOW DO MONOCLONAL ANTIBODIES INDUCE TOLERANCE? A Role for Infectious Tolerance?
1998 • 223 citations
The generation of a humanized, non‐mitogenic CD3 monoclonal antibody which retains in vitro immunosuppressive properties
1993 • 217 citations
Spontaneous Diabetes Mellitus: Reversal and Prevention in the BB/W Rat with Antiserum to Rat Lymphocytes
1979 • 212 citations
Effects of in vivo administration of anti-CD3 monoclonal antibody on T cell function in mice. II. In vivo activation of T cells.
1989 • 198 citations
Auto- and alloimmune reactivity to human islet allografts transplanted into type 1 diabetic patients.
1999 • 183 citations
Anti-interleukin 2 receptor antibody suppresses murine diabetic insulitis and lupus nephritis.
1988 • 141 citations
PHASE I STUDY OF AN ENGINEERED AGLYCOSYLATED HUMANIZED CD3 ANTIBODY IN RENAL TRANSPLANT REJECTION1
1999 • 140 citations
Inhibition of insulitis and prevention of diabetes in nonobese diabetic mice by blocking L-selectin and very late antigen 4 adhesion receptors.
1993 • 127 citations
In vivo induction of interleukin 10 by anti-CD3 monoclonal antibody or bacterial lipopolysaccharide: differential modulation by cyclosporin A.
1993 • 124 citations
ANTI-CD3 F(abʼ)2 FRAGMENTS ARE IMMUNOSUPPRESSIVE IN VIVO WITHOUT EVOKING EITHER THE STRONG HUMORAL RESPONSE OR MORBIDITY ASSOCIATED WITH WHOLE mAb
1990 • 124 citations
Insulin-dependent diabetes mellitus as an autoimmune disease
1994 • 103 citations
Spontaneous Diabetes in Rats: Destruction of Islets Is Prevented by Immunological Tolerance
1981 • 101 citations
Induction of T cell proliferation with anti‐CD3 switch‐variant monoclonal antibodies: effects of heavy chain isotype in monocyte‐dependent systems
1987 • 90 citations
Use of homozygous allogeneic bone marrow for induction of tolerance with antilymphocyte serum: dose and timing.
1971 • 86 citations
Neonatal activation of CD28 signaling overcomes T cell anergy and prevents autoimmune diabetes by an IL-4-dependent mechanism.
1997 • 85 citations
In vivo prevention of thyroid and pancreatic autoimmunity in the BB rat by antibody to class II major histocompatibility complex gene products.
1985 • 79 citations
Susceptibility to diabetes is widely distributed in normal class IIu haplotype rats
2000 • 78 citations
Induction of tolerance in murine autoimmune diabetes by transient blockade of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 pathway.
1996 • 72 citations
Induction of T helper cell hyporesponsiveness in an experimental model of autoimmunity by using nonmitogenic anti-CD3 monoclonal antibody.
1994 • 72 citations
Prevention of autoimmune insulin-dependent diabetes in non-obese diabetic mice by anti-LFA-1 and anti-ICAM-1 mAb
1994 • 71 citations
Curing BB rats of freshly manifested diabetes by short‐term treatment with a combination of a monoclonal anti‐interleukin 2 receptor antibody and a subtherapeutic dose of cyclosporin A
1987 • 57 citations
Type-I Diabetes: A Chronic Autoimmune Disease Of Human, Mouse, And Rat
1990 • 47 citations
Prevention of autoimmune recurrence and rejection by adenovirus-mediated CTLA4Ig gene transfer to the pancreatic graft in BB rat.
1999 • 47 citations
Long-term function (6 years) of islet allografts in type 1 diabetes
1997 • 39 citations
Anti-CD3 antibodies induce T cells from unprimed animals to secrete IL-4 both in vitro and in vivo.
1990 • 39 citations
Use of anti-CD3 epsilon F(ab')2 fragments in vivo to modulate graft-versus-host disease without loss of graft-versus-leukemia reactivity after MHC-matched bone marrow transplantation.
1995 • 38 citations
Differential T cell hyporesponsiveness induced by in vivo administration of intact or F(ab')2 fragments of anti-CD3 monoclonal antibody. F(ab')2 fragments induce a selective T helper dysfunction.
1991 • 36 citations
Prevention of autoimmune diabetes with nonactivating anti-CD3 monoclonal antibody
1992 • 36 citations
Transplantation of pancreas and islets of Langerhans: a review of progress
1996 • 18 citations
Pancreas Transplantation
1999 • 10 citations
Islet transplantation in spontaneously diabetic BB/Wor rats
1989 • 4 citations
Recurrence of Autoimmune Diabetes Mellitus in Recipients of Cadaveric Pancreatic Grafts
1996 • 4 citations
Islet Cell Transplantation: Beyond the Paradigms
1996 • 3 citations
CONTRASTING IN VIVO EFFECTS ON T HELPER CELL FUNCTIONS INDUCED BY MITOGENIC (INTACT) VERSUS NONMITOGENIC (F(abʼ2) ANTI-CD3 MONOCLONAL ANTIBODY
1995 • 1 citations
Cited By (0)
No citing papers found in database